Quality of life trajectory in breast cancer survivors: A longitudinal, two-year post treatment follow-up study.
코호트
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
338 patients, 63 (18.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] The U-shaped QOL trajectory highlights the need for interventions at 3-6 months post-treatment, particularly for body image and physical function. These findings provide a foundation for targeted supportive care in Indian breast cancer survivors.
[BACKGROUND] Advances in breast cancer treatment have improved survival, making Quality of Life (QOL) a critical endpoint.
- p-value p < 0.001
- 연구 설계 cohort study
APA
Pathania A, Kr S, et al. (2026). Quality of life trajectory in breast cancer survivors: A longitudinal, two-year post treatment follow-up study.. Journal of psychosomatic research, 203, 112551. https://doi.org/10.1016/j.jpsychores.2026.112551
MLA
Pathania A, et al.. "Quality of life trajectory in breast cancer survivors: A longitudinal, two-year post treatment follow-up study.." Journal of psychosomatic research, vol. 203, 2026, pp. 112551.
PMID
41592457 ↗
Abstract 한글 요약
[BACKGROUND] Advances in breast cancer treatment have improved survival, making Quality of Life (QOL) a critical endpoint. This study examines longitudinal QOL in Indian breast cancer survivors using the Functional Assessment of Cancer Therapy for Breast (FACT-B) questionnaire.
[METHODS] A longitudinal cohort study followed 338 women with curable breast cancer, assessing QOL at baseline (before treatment), 3 months, 6 months, 12 months, and 24 months post-treatment. The FACT-B provided total and subscale scores (Physical, Social, Emotional, Functional, and Breast-specific well-being).
[RESULTS] Of 338 patients, 63 (18.64%) completed all assessments up to 24 months, and 68 (20.12%) completed up to 12 months. QOL decreased significantly at 3 months post-treatment (mean 74.98 vs. 85.6 at baseline, p < 0.001), remained below baseline at 6 months (79.34, p < 0.001), returned to baseline by 12 months (87.94, p = 0.147), and improved significantly by 24 months (110.92, p < 0.001). Physical and Functional well-being showed early declines, Social and Emotional well-being remained stable or improved, and Breast-specific well-being remained low, reflecting body image concerns.
[CONCLUSION] The U-shaped QOL trajectory highlights the need for interventions at 3-6 months post-treatment, particularly for body image and physical function. These findings provide a foundation for targeted supportive care in Indian breast cancer survivors.
[METHODS] A longitudinal cohort study followed 338 women with curable breast cancer, assessing QOL at baseline (before treatment), 3 months, 6 months, 12 months, and 24 months post-treatment. The FACT-B provided total and subscale scores (Physical, Social, Emotional, Functional, and Breast-specific well-being).
[RESULTS] Of 338 patients, 63 (18.64%) completed all assessments up to 24 months, and 68 (20.12%) completed up to 12 months. QOL decreased significantly at 3 months post-treatment (mean 74.98 vs. 85.6 at baseline, p < 0.001), remained below baseline at 6 months (79.34, p < 0.001), returned to baseline by 12 months (87.94, p = 0.147), and improved significantly by 24 months (110.92, p < 0.001). Physical and Functional well-being showed early declines, Social and Emotional well-being remained stable or improved, and Breast-specific well-being remained low, reflecting body image concerns.
[CONCLUSION] The U-shaped QOL trajectory highlights the need for interventions at 3-6 months post-treatment, particularly for body image and physical function. These findings provide a foundation for targeted supportive care in Indian breast cancer survivors.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.